APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

mRNA Vaccines & Therapeutics

mRNA is a rather versatile technology and offers a number of advantages. mRNA lacks genomic integration and its use results in transient expression of the encoded protein. This favorable safety profile makes mRNA especially attractive for vaccines and gene editing. mRNA is well defined chemically which ensures reproducible manufacturing at high yield, purity and activity. Improvements of lipid nanoparticle formulations as a vehicle for in vivo systemic delivery of mRNA has greatly favored the development of in vivo transfection strategies.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

mRNA is a rather versatile technology and offers a number of advantages. mRNA lacks genomic integration and its use results in transient expression of the encoded protein. This favorable safety profile makes mRNA especially attractive for vaccines and gene editing. mRNA is well defined chemically which ensures reproducible manufacturing at high yield, purity and activity. Improvements of lipid nanoparticle formulations as a vehicle for in vivo systemic delivery of mRNA has greatly favored the development of in vivo transfection strategies.

Selected research

Industry Growth & Trends

Global mRNA Vaccines & Therapeutics Industry Growth and Trends Forecast to 2032

Report ID 174014630128 December 2025100 pages

Choose your research edition.

Industry ResearchmRNA Vaccines & Therapeutics Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal mRNA Vaccines & Therapeutics Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal mRNA Vaccines & Therapeutics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal mRNA Vaccines & Therapeutics Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal mRNA Vaccines & Therapeutics Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

mRNA is a rather versatile technology and offers a number of advantages. mRNA lacks genomic integration and its use results in transient expression of the encoded protein. This favorable safety profile makes mRNA especially attractive for vaccines and gene editing. mRNA is well defined chemically which ensures reproducible manufacturing at high yield, purity and activity. Improvements of lipid nanoparticle formulations as a vehicle for in vivo systemic delivery of mRNA has greatly favored the development of in vivo transfection strategies.

Global core mRNA vaccines & therapeutics manufacturers include Moderna Therapeutics, CureVac etc. The top 3 companies hold a share about 65%. Europe is the largest market, with a share about 10%, followed by Asia Pacific and North America.

Report Scope

Read the full market overview

This report provides a structured, data-driven view of the global mRNA Vaccines & Therapeutics market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The mRNA Vaccines & Therapeutics market size, estimates, and forecasts are presented in terms of sales volume (M Doses) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global mRNA Vaccines & Therapeutics market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to mRNA Vaccines & Therapeutics.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global mRNA Vaccines & Therapeutics market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

mRNA Vaccines & Therapeutics Market by Company

Moderna Therapeutics

CureVac

Translate Bio

BioNTech

Sangamo Therapeutics

Argos Therapeutics

In-Cell-Art

eTheRNA

Ethris

Tiba Biotechnology

mRNA Vaccines & Therapeutics Segment by Type

Infectious Disease Vaccines

Cancer Vaccines

mRNA Vaccines & Therapeutics Segment by Application

Infectious Disease

Cancer

mRNA Vaccines & Therapeutics Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global mRNA Vaccines & Therapeutics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of mRNA Vaccines & Therapeutics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of mRNA Vaccines & Therapeutics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of mRNA Vaccines & Therapeutics manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of mRNA Vaccines & Therapeutics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Infectious Disease Vaccines Table 2. Major Company of Cancer Vaccines Table 3. Global mRNA Vaccines & Therapeutics Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global mRNA Vaccines & Therapeutics Sales by Type (2021-2026) & (M Doses) Table 5. Global mRNA Vaccines & Therapeutics Sales Market Share in Volume by Type (2021-2026) Table 6. Global mRNA Vaccines & Therapeutics Sales by Type (2021-2026) & (US$ Million) Table 7. Global mRNA Vaccines & Therapeutics Sales Market Share in Value by Type (2021-2026) Table 8. Global mRNA Vaccines & Therapeutics Price by Type (2021-2026) & (USD/Doses) Table 9. Global mRNA Vaccines & Therapeutics Sales by Type (2027-2032) & (M Doses) Table 10. Global mRNA Vaccines & Therapeutics Sales Market Share in Volume by Type (2027-2032) Table 11. Global mRNA Vaccines & Therapeutics Sales by Type (2027-2032) & (US$ Million) Table 12. Global mRNA Vaccines & Therapeutics Sales Market Share in Value by Type (2027-2032) Table 13. Global mRNA Vaccines & Therapeutics Price by Type (2027-2032) & (USD/Doses) Table 14. North America mRNA Vaccines & Therapeutics Sales by Type (2021-2026) & (M Doses) Table 15. North America mRNA Vaccines & Therapeutics Sales by Type (2021-2026) & (US$ Million) Table 16. Europe mRNA Vaccines & Therapeutics Sales by Type (2021-2026) & (M Doses) Table 17. Europe mRNA Vaccines & Therapeutics Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific mRNA Vaccines & Therapeutics Sales by Type (2021-2026) & (M Doses) Table 19. Asia-Pacific mRNA Vaccines & Therapeutics Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America mRNA Vaccines & Therapeutics Sales by Type (2021-2026) & (M Doses) Table 21. Latin America mRNA Vaccines & Therapeutics Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa mRNA Vaccines & Therapeutics Sales by Type (2021-2026) & (M Doses) Table 23. Middle East and Africa mRNA Vaccines & Therapeutics Sales by Type (2021-2026) & (US$ Million) Table 24. mRNA Vaccines & Therapeutics Industry Trends Table 25. mRNA Vaccines & Therapeutics Industry Drivers Table 26. mRNA Vaccines & Therapeutics Industry Opportunities and Challenges Table 27. mRNA Vaccines & Therapeutics Industry Restraints Table 28. Global mRNA Vaccines & Therapeutics Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global mRNA Vaccines & Therapeutics Revenue Market Share by Company (2021-2026) Table 30. Global mRNA Vaccines & Therapeutics Sales by Company (2021-2026) & (M Doses) Table 31. Global mRNA Vaccines & Therapeutics Sales Share by Company (2021-2026) Table 32. Global mRNA Vaccines & Therapeutics Market Price by Company (2021-2026) & (USD/Doses) Table 33. Global mRNA Vaccines & Therapeutics Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global mRNA Vaccines & Therapeutics Major Company Production Sites and Headquarters Table 35. Global mRNA Vaccines & Therapeutics Company, Product Type & Application Table 36. Global mRNA Vaccines & Therapeutics Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global mRNA Vaccines & Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global mRNA Vaccines & Therapeutics Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global mRNA Vaccines & Therapeutics Sales by Region (2021-2026) & (M Doses) Table 41. Global mRNA Vaccines & Therapeutics Sales Market Share in Volume by Region (2021-2026) Table 42. Global mRNA Vaccines & Therapeutics Sales by Region (2021-2026) & (US$ Million) Table 43. Global mRNA Vaccines & Therapeutics Sales Market Share in Value by Region (2021-2026) Table 44. Global mRNA Vaccines & Therapeutics Sales (M Doses), Value (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026) Table 45. Global mRNA Vaccines & Therapeutics Sales by Region (2027-2032) & (M Doses) Table 46. Global mRNA Vaccines & Therapeutics Sales Market Share in Volume by Region (2027-2032) Table 47. Global mRNA Vaccines & Therapeutics Sales by Region (2027-2032) & (US$ Million) Table 48. Global mRNA Vaccines & Therapeutics Sales Market Share in Value by Region (2027-2032) Table 49. Global mRNA Vaccines & Therapeutics Sales (M Doses), Value (US$ Million), Price (USD/Doses) and Gross Margin (2027-2032) Table 50. Global mRNA Vaccines & Therapeutics Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global mRNA Vaccines & Therapeutics Sales by Application (2021-2026) & (M Doses) Table 52. Global mRNA Vaccines & Therapeutics Sales Market Share in Volume by Application (2021-2026) Table 53. Global mRNA Vaccines & Therapeutics Sales by Application (2021-2026) & (US$ Million) Table 54. Global mRNA Vaccines & Therapeutics Sales Market Share in Value by Application (2021-2026) Table 55. Global mRNA Vaccines & Therapeutics Price by Application (2021-2026) & (USD/Doses) Table 56. Global mRNA Vaccines & Therapeutics Sales by Application (2027-2032) & (M Doses) Table 57. Global mRNA Vaccines & Therapeutics Sales Market Share in Volume by Application (2027-2032) Table 58. Global mRNA Vaccines & Therapeutics Sales by Application (2027-2032) & (US$ Million) Table 59. Global mRNA Vaccines & Therapeutics Sales Market Share in Value by Application (2027-2032) Table 60. Global mRNA Vaccines & Therapeutics Price by Application (2027-2032) & (USD/Doses) Table 61. North America mRNA Vaccines & Therapeutics Sales by Application (2021-2026) & (M Doses) Table 62. North America mRNA Vaccines & Therapeutics Sales by Application (2021-2026) & (US$ Million) Table 63. Europe mRNA Vaccines & Therapeutics Sales by Application (2021-2026) & (M Doses) Table 64. Europe mRNA Vaccines & Therapeutics Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific mRNA Vaccines & Therapeutics Sales by Application (2021-2026) & (M Doses) Table 66. Asia-Pacific mRNA Vaccines & Therapeutics Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America mRNA Vaccines & Therapeutics Sales by Application (2021-2026) & (M Doses) Table 68. Latin America mRNA Vaccines & Therapeutics Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa mRNA Vaccines & Therapeutics Sales by Application (2021-2026) & (M Doses) Table 70. Middle East and Africa mRNA Vaccines & Therapeutics Sales by Application (2021-2026) & (US$ Million) Table 71. Moderna Therapeutics Company Information Table 72. Moderna Therapeutics Business Overview Table 73. Moderna Therapeutics mRNA Vaccines & Therapeutics Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026) Table 74. Moderna Therapeutics mRNA Vaccines & Therapeutics Product Portfolio Table 75. Moderna Therapeutics Recent Development Table 76. CureVac Company Information Table 77. CureVac Business Overview Table 78. CureVac mRNA Vaccines & Therapeutics Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026) Table 79. CureVac mRNA Vaccines & Therapeutics Product Portfolio Table 80. CureVac Recent Development Table 81. Translate Bio Company Information Table 82. Translate Bio Business Overview Table 83. Translate Bio mRNA Vaccines & Therapeutics Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026) Table 84. Translate Bio mRNA Vaccines & Therapeutics Product Portfolio Table 85. Translate Bio Recent Development Table 86. BioNTech Company Information Table 87. BioNTech Business Overview Table 88. BioNTech mRNA Vaccines & Therapeutics Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026) Table 89. BioNTech mRNA Vaccines & Therapeutics Product Portfolio Table 90. BioNTech Recent Development Table 91. Sangamo Therapeutics Company Information Table 92. Sangamo Therapeutics Business Overview Table 93. Sangamo Therapeutics mRNA Vaccines & Therapeutics Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026) Table 94. Sangamo Therapeutics mRNA Vaccines & Therapeutics Product Portfolio Table 95. Sangamo Therapeutics Recent Development Table 96. Argos Therapeutics Company Information Table 97. Argos Therapeutics Business Overview Table 98. Argos Therapeutics mRNA Vaccines & Therapeutics Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026) Table 99. Argos Therapeutics mRNA Vaccines & Therapeutics Product Portfolio Table 100. Argos Therapeutics Recent Development Table 101. In-Cell-Art Company Information Table 102. In-Cell-Art Business Overview Table 103. In-Cell-Art mRNA Vaccines & Therapeutics Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026) Table 104. In-Cell-Art mRNA Vaccines & Therapeutics Product Portfolio Table 105. In-Cell-Art Recent Development Table 106. eTheRNA Company Information Table 107. eTheRNA Business Overview Table 108. eTheRNA mRNA Vaccines & Therapeutics Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026) Table 109. eTheRNA mRNA Vaccines & Therapeutics Product Portfolio Table 110. eTheRNA Recent Development Table 111. Ethris Company Information Table 112. Ethris Business Overview Table 113. Ethris mRNA Vaccines & Therapeutics Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026) Table 114. Ethris mRNA Vaccines & Therapeutics Product Portfolio Table 115. Ethris Recent Development Table 116. Tiba Biotechnology Company Information Table 117. Tiba Biotechnology Business Overview Table 118. Tiba Biotechnology mRNA Vaccines & Therapeutics Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026) Table 119. Tiba Biotechnology mRNA Vaccines & Therapeutics Product Portfolio Table 120. Tiba Biotechnology Recent Development Table 121. North America mRNA Vaccines & Therapeutics Market Size Growth Rate (CAGR) by Country (M Doses): 2021 VS 2025 VS 2032 Table 122. North America mRNA Vaccines & Therapeutics Sales by Country (2021-2026) & (M Doses) Table 123. North America mRNA Vaccines & Therapeutics Sales Market Share by Country (2021-2026) Table 124. North America mRNA Vaccines & Therapeutics Sales Forecast by Country (2027-2032) & (M Doses) Table 125. North America mRNA Vaccines & Therapeutics Sales Market Share Forecast by Country (2027-2032) Table 126. North America mRNA Vaccines & Therapeutics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. North America mRNA Vaccines & Therapeutics Market Size by Country (2021-2026) & (US$ Million) Table 128. North America mRNA Vaccines & Therapeutics Market Share by Country (2021-2026) Table 129. North America mRNA Vaccines & Therapeutics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. North America mRNA Vaccines & Therapeutics Market Share Forecast by Country (2027-2032) Table 131. Europe mRNA Vaccines & Therapeutics Market Size Growth Rate (CAGR) by Country (M Doses): 2021 VS 2025 VS 2032 Table 132. Europe mRNA Vaccines & Therapeutics Sales by Country (2021-2026) & (M Doses) Table 133. Europe mRNA Vaccines & Therapeutics Sales Market Share by Country (2021-2026) Table 134. Europe mRNA Vaccines & Therapeutics Sales Forecast by Country (2027-2032) & (M Doses) Table 135. Europe mRNA Vaccines & Therapeutics Sales Market Share Forecast by Country (2027-2032) Table 136. Europe mRNA Vaccines & Therapeutics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Europe mRNA Vaccines & Therapeutics Market Size by Country (2021-2026) & (US$ Million) Table 138. Europe mRNA Vaccines & Therapeutics Market Share by Country (2021-2026) Table 139. Europe mRNA Vaccines & Therapeutics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Europe mRNA Vaccines & Therapeutics Market Share Forecast by Country (2027-2032) Table 141. Asia-Pacific mRNA Vaccines & Therapeutics Market Size Growth Rate (CAGR) by Country (M Doses): 2021 VS 2025 VS 2032 Table 142. Asia-Pacific mRNA Vaccines & Therapeutics Sales by Country (2021-2026) & (M Doses) Table 143. Asia-Pacific mRNA Vaccines & Therapeutics Sales Market Share by Country (2021-2026) Table 144. Asia-Pacific mRNA Vaccines & Therapeutics Sales Forecast by Country (2027-2032) & (M Doses) Table 145. Asia-Pacific mRNA Vaccines & Therapeutics Sales Market Share Forecast by Country (2027-2032) Table 146. Asia-Pacific mRNA Vaccines & Therapeutics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Asia-Pacific mRNA Vaccines & Therapeutics Market Size by Country (2021-2026) & (US$ Million) Table 148. Asia-Pacific mRNA Vaccines & Therapeutics Market Share by Country (2021-2026) Table 149. Asia-Pacific mRNA Vaccines & Therapeutics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Asia-Pacific mRNA Vaccines & Therapeutics Market Share Forecast by Country (2027-2032) Table 151. Latin America mRNA Vaccines & Therapeutics Market Size Growth Rate (CAGR) by Country (M Doses): 2021 VS 2025 VS 2032 Table 152. Latin America mRNA Vaccines & Therapeutics Sales by Country (2021-2026) & (M Doses) Table 153. Latin America mRNA Vaccines & Therapeutics Sales Market Share by Country (2021-2026) Table 154. Latin America mRNA Vaccines & Therapeutics Sales Forecast by Country (2027-2032) & (M Doses) Table 155. Latin America mRNA Vaccines & Therapeutics Sales Market Share Forecast by Country (2027-2032) Table 156. Latin America mRNA Vaccines & Therapeutics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Latin America mRNA Vaccines & Therapeutics Market Size by Country (2021-2026) & (US$ Million) Table 158. Latin America mRNA Vaccines & Therapeutics Market Share by Country (2021-2026) Table 159. Latin America mRNA Vaccines & Therapeutics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Latin America mRNA Vaccines & Therapeutics Market Share Forecast by Country (2027-2032) Table 161. Middle East and Africa mRNA Vaccines & Therapeutics Market Size Growth Rate (CAGR) by Country (M Doses): 2021 VS 2025 VS 2032 Table 162. Middle East and Africa mRNA Vaccines & Therapeutics Sales by Country (2021-2026) & (M Doses) Table 163. Middle East and Africa mRNA Vaccines & Therapeutics Sales Market Share by Country (2021-2026) Table 164. Middle East and Africa mRNA Vaccines & Therapeutics Sales Forecast by Country (2027-2032) & (M Doses) Table 165. Middle East and Africa mRNA Vaccines & Therapeutics Sales Market Share Forecast by Country (2027-2032) Table 166. Middle East and Africa mRNA Vaccines & Therapeutics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. Middle East and Africa mRNA Vaccines & Therapeutics Market Size by Country (2021-2026) & (US$ Million) Table 168. Middle East and Africa mRNA Vaccines & Therapeutics Market Share by Country (2021-2026) Table 169. Middle East and Africa mRNA Vaccines & Therapeutics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. Middle East and Africa mRNA Vaccines & Therapeutics Market Share Forecast by Country (2027-2032) Table 171. Key Raw Materials Table 172. Raw Materials Key Suppliers Table 173. mRNA Vaccines & Therapeutics Distributors List Table 174. mRNA Vaccines & Therapeutics Customers List Table 175. Research Programs/Design for This Report Table 176. Authors List of This Report Table 177. Secondary Sources Table 178. Primary Sources List of Figures Figure 1. mRNA Vaccines & Therapeutics Image Figure 2. Global mRNA Vaccines & Therapeutics Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global mRNA Vaccines & Therapeutics Market Size (2021-2032) & (US$ Million) Figure 4. Global mRNA Vaccines & Therapeutics Sales (2021-2032) & (M Doses) Figure 5. Infectious Disease Vaccines Image Figure 6. Global Infectious Disease Vaccines Sales YoY Growth (2021-2032) & (M Doses) Figure 7. Cancer Vaccines Image Figure 8. Global Cancer Vaccines Sales YoY Growth (2021-2032) & (M Doses) Figure 9. Global mRNA Vaccines & Therapeutics Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global mRNA Vaccines & Therapeutics Market Share by Type 2025 VS 2032 Figure 11. North America mRNA Vaccines & Therapeutics Sales Market Share in Volume by Type in 2025 Figure 12. North America mRNA Vaccines & Therapeutics Sales Market Share in Value by Type in 2025 Figure 13. Europe mRNA Vaccines & Therapeutics Sales Market Share in Volume by Type in 2025 Figure 14. Europe mRNA Vaccines & Therapeutics Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific mRNA Vaccines & Therapeutics Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific mRNA Vaccines & Therapeutics Sales Market Share in Value by Type in 2025 Figure 17. Latin America mRNA Vaccines & Therapeutics Sales Market Share in Volume by Type in 2025 Figure 18. Latin America mRNA Vaccines & Therapeutics Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa mRNA Vaccines & Therapeutics Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa mRNA Vaccines & Therapeutics Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 mRNA Vaccines & Therapeutics Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Infectious Disease Image Figure 24. Global Infectious Disease Sales YoY Growth (2021-2032) & (M Doses) Figure 25. Cancer Image Figure 26. Global Cancer Sales YoY Growth (2021-2032) & (M Doses) Figure 27. Global mRNA Vaccines & Therapeutics Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global mRNA Vaccines & Therapeutics Market Share by Application 2025 VS 2032 Figure 29. North America mRNA Vaccines & Therapeutics Sales Market Share in Volume by Application in 2025 Figure 30. North America mRNA Vaccines & Therapeutics Sales Market Share in Value by Application in 2025 Figure 31. Europe mRNA Vaccines & Therapeutics Sales Market Share in Volume by Application in 2025 Figure 32. Europe mRNA Vaccines & Therapeutics Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific mRNA Vaccines & Therapeutics Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific mRNA Vaccines & Therapeutics Sales Market Share in Value by Application in 2025 Figure 35. Latin America mRNA Vaccines & Therapeutics Sales Market Share in Volume by Application in 2025 Figure 36. Latin America mRNA Vaccines & Therapeutics Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa mRNA Vaccines & Therapeutics Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa mRNA Vaccines & Therapeutics Sales Market Share in Value by Application in 2025 Figure 39. North America mRNA Vaccines & Therapeutics Sales by Country: 2021 VS 2025 VS 2032 (M Doses) Figure 40. North America mRNA Vaccines & Therapeutics Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America mRNA Vaccines & Therapeutics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America mRNA Vaccines & Therapeutics Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe mRNA Vaccines & Therapeutics Sales by Country: 2021 VS 2025 VS 2032 (M Doses) Figure 44. Europe mRNA Vaccines & Therapeutics Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe mRNA Vaccines & Therapeutics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe mRNA Vaccines & Therapeutics Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific mRNA Vaccines & Therapeutics Sales by Country: 2021 VS 2025 VS 2032 (M Doses) Figure 48. Asia-Pacific mRNA Vaccines & Therapeutics Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific mRNA Vaccines & Therapeutics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific mRNA Vaccines & Therapeutics Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America mRNA Vaccines & Therapeutics Sales by Country: 2021 VS 2025 VS 2032 (M Doses) Figure 52. Latin America mRNA Vaccines & Therapeutics Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America mRNA Vaccines & Therapeutics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America mRNA Vaccines & Therapeutics Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa mRNA Vaccines & Therapeutics Sales by Country: 2021 VS 2025 VS 2032 (M Doses) Figure 56. Middle East and Africa mRNA Vaccines & Therapeutics Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa mRNA Vaccines & Therapeutics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa mRNA Vaccines & Therapeutics Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. mRNA Vaccines & Therapeutics Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. mRNA Vaccines & Therapeutics Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Infectious Disease Vaccines
  • Cancer Vaccines
Applications
  • Infectious Disease
  • Cancer
Companies covered
  • Moderna Therapeutics
  • CureVac
  • Translate Bio
  • BioNTech
  • Sangamo Therapeutics
  • Argos Therapeutics
  • In-Cell-Art
  • eTheRNA
  • Ethris
  • Tiba Biotechnology

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global mRNA Vaccines & Therapeutics Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global mRNA Vaccines & Therapeutics Sales Estimates and Forecasts (2021-2032)
  5. 1.3 mRNA Vaccines & Therapeutics Market by Type
  6. 1.3.1 Infectious Disease Vaccines
  7. 1.3.2 Cancer Vaccines
  8. 1.4 Global mRNA Vaccines & Therapeutics Market Size by Type
  9. 1.4.1 Global mRNA Vaccines & Therapeutics Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global mRNA Vaccines & Therapeutics Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global mRNA Vaccines & Therapeutics Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America mRNA Vaccines & Therapeutics Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe mRNA Vaccines & Therapeutics Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific mRNA Vaccines & Therapeutics Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America mRNA Vaccines & Therapeutics Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa mRNA Vaccines & Therapeutics Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 mRNA Vaccines & Therapeutics Industry Trends
  2. 2.2 mRNA Vaccines & Therapeutics Industry Drivers
  3. 2.3 mRNA Vaccines & Therapeutics Industry Opportunities and Challenges
  4. 2.4 mRNA Vaccines & Therapeutics Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by mRNA Vaccines & Therapeutics Revenue (2021-2026)
  2. 3.2 Global Top Players by mRNA Vaccines & Therapeutics Sales (2021-2026)
  3. 3.3 Global Top Players by mRNA Vaccines & Therapeutics Price (2021-2026)
  4. 3.4 Global mRNA Vaccines & Therapeutics Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global mRNA Vaccines & Therapeutics Major Company Production Sites & Headquarters
  6. 3.6 Global mRNA Vaccines & Therapeutics Company, Product Type & Application
  7. 3.7 Global mRNA Vaccines & Therapeutics Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global mRNA Vaccines & Therapeutics Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 mRNA Vaccines & Therapeutics Players Market Share by Revenue in 2025
  11. 3.8.3 2025 mRNA Vaccines & Therapeutics Tier 1, Tier 2, and Tier 3
4 mRNA Vaccines & Therapeutics Regional Status and Outlook
  1. 4.1 Global mRNA Vaccines & Therapeutics Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global mRNA Vaccines & Therapeutics Historic Market Size by Region
  3. 4.2.1 Global mRNA Vaccines & Therapeutics Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global mRNA Vaccines & Therapeutics Sales in Value by Region (2021-2026)
  5. 4.2.3 Global mRNA Vaccines & Therapeutics Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global mRNA Vaccines & Therapeutics Forecasted Market Size by Region
  7. 4.3.1 Global mRNA Vaccines & Therapeutics Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global mRNA Vaccines & Therapeutics Sales in Value by Region (2027-2032)
  9. 4.3.3 Global mRNA Vaccines & Therapeutics Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 mRNA Vaccines & Therapeutics by Application
  1. 5.1 mRNA Vaccines & Therapeutics Market by Application
  2. 5.1.1 Infectious Disease
  3. 5.1.2 Cancer
  4. 5.2 Global mRNA Vaccines & Therapeutics Market Size by Application
  5. 5.2.1 Global mRNA Vaccines & Therapeutics Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global mRNA Vaccines & Therapeutics Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global mRNA Vaccines & Therapeutics Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America mRNA Vaccines & Therapeutics Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe mRNA Vaccines & Therapeutics Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific mRNA Vaccines & Therapeutics Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America mRNA Vaccines & Therapeutics Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa mRNA Vaccines & Therapeutics Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Moderna Therapeutics
  2. 6.1.1 Moderna Therapeutics Company Information
  3. 6.1.2 Moderna Therapeutics Business Overview
  4. 6.1.3 Moderna Therapeutics mRNA Vaccines & Therapeutics Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Moderna Therapeutics mRNA Vaccines & Therapeutics Product Portfolio
  6. 6.1.5 Moderna Therapeutics Recent Developments
  7. 6.2 CureVac
  8. 6.2.1 CureVac Company Information
  9. 6.2.2 CureVac Business Overview
  10. 6.2.3 CureVac mRNA Vaccines & Therapeutics Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 CureVac mRNA Vaccines & Therapeutics Product Portfolio
  12. 6.2.5 CureVac Recent Developments
  13. 6.3 Translate Bio
  14. 6.3.1 Translate Bio Company Information
  15. 6.3.2 Translate Bio Business Overview
  16. 6.3.3 Translate Bio mRNA Vaccines & Therapeutics Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Translate Bio mRNA Vaccines & Therapeutics Product Portfolio
  18. 6.3.5 Translate Bio Recent Developments
  19. 6.4 BioNTech
  20. 6.4.1 BioNTech Company Information
  21. 6.4.2 BioNTech Business Overview
  22. 6.4.3 BioNTech mRNA Vaccines & Therapeutics Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 BioNTech mRNA Vaccines & Therapeutics Product Portfolio
  24. 6.4.5 BioNTech Recent Developments
  25. 6.5 Sangamo Therapeutics
  26. 6.5.1 Sangamo Therapeutics Company Information
  27. 6.5.2 Sangamo Therapeutics Business Overview
  28. 6.5.3 Sangamo Therapeutics mRNA Vaccines & Therapeutics Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Sangamo Therapeutics mRNA Vaccines & Therapeutics Product Portfolio
  30. 6.5.5 Sangamo Therapeutics Recent Developments
  31. 6.6 Argos Therapeutics
  32. 6.6.1 Argos Therapeutics Company Information
  33. 6.6.2 Argos Therapeutics Business Overview
  34. 6.6.3 Argos Therapeutics mRNA Vaccines & Therapeutics Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Argos Therapeutics mRNA Vaccines & Therapeutics Product Portfolio
  36. 6.6.5 Argos Therapeutics Recent Developments
  37. 6.7 In-Cell-Art
  38. 6.7.1 In-Cell-Art Company Information
  39. 6.7.2 In-Cell-Art Business Overview
  40. 6.7.3 In-Cell-Art mRNA Vaccines & Therapeutics Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 In-Cell-Art mRNA Vaccines & Therapeutics Product Portfolio
  42. 6.7.5 In-Cell-Art Recent Developments
  43. 6.8 eTheRNA
  44. 6.8.1 eTheRNA Company Information
  45. 6.8.2 eTheRNA Business Overview
  46. 6.8.3 eTheRNA mRNA Vaccines & Therapeutics Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 eTheRNA mRNA Vaccines & Therapeutics Product Portfolio
  48. 6.8.5 eTheRNA Recent Developments
  49. 6.9 Ethris
  50. 6.9.1 Ethris Company Information
  51. 6.9.2 Ethris Business Overview
  52. 6.9.3 Ethris mRNA Vaccines & Therapeutics Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Ethris mRNA Vaccines & Therapeutics Product Portfolio
  54. 6.9.5 Ethris Recent Developments
  55. 6.10 Tiba Biotechnology
  56. 6.10.1 Tiba Biotechnology Company Information
  57. 6.10.2 Tiba Biotechnology Business Overview
  58. 6.10.3 Tiba Biotechnology mRNA Vaccines & Therapeutics Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Tiba Biotechnology mRNA Vaccines & Therapeutics Product Portfolio
  60. 6.10.5 Tiba Biotechnology Recent Developments
7 North America by Country
  1. 7.1 North America mRNA Vaccines & Therapeutics Sales by Country
  2. 7.1.1 North America mRNA Vaccines & Therapeutics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America mRNA Vaccines & Therapeutics Sales by Country (2021-2026)
  4. 7.1.3 North America mRNA Vaccines & Therapeutics Sales Forecast by Country (2027-2032)
  5. 7.2 North America mRNA Vaccines & Therapeutics Market Size by Country
  6. 7.2.1 North America mRNA Vaccines & Therapeutics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America mRNA Vaccines & Therapeutics Market Size by Country (2021-2026)
  8. 7.2.3 North America mRNA Vaccines & Therapeutics Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe mRNA Vaccines & Therapeutics Sales by Country
  2. 8.1.1 Europe mRNA Vaccines & Therapeutics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe mRNA Vaccines & Therapeutics Sales by Country (2021-2026)
  4. 8.1.3 Europe mRNA Vaccines & Therapeutics Sales Forecast by Country (2027-2032)
  5. 8.2 Europe mRNA Vaccines & Therapeutics Market Size by Country
  6. 8.2.1 Europe mRNA Vaccines & Therapeutics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe mRNA Vaccines & Therapeutics Market Size by Country (2021-2026)
  8. 8.2.3 Europe mRNA Vaccines & Therapeutics Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific mRNA Vaccines & Therapeutics Sales by Country
  2. 9.1.1 Asia-Pacific mRNA Vaccines & Therapeutics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific mRNA Vaccines & Therapeutics Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific mRNA Vaccines & Therapeutics Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific mRNA Vaccines & Therapeutics Market Size by Country
  6. 9.2.1 Asia-Pacific mRNA Vaccines & Therapeutics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific mRNA Vaccines & Therapeutics Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific mRNA Vaccines & Therapeutics Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America mRNA Vaccines & Therapeutics Sales by Country
  2. 10.1.1 South America mRNA Vaccines & Therapeutics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America mRNA Vaccines & Therapeutics Sales by Country (2021-2026)
  4. 10.1.3 South America mRNA Vaccines & Therapeutics Sales Forecast by Country (2027-2032)
  5. 10.2 South America mRNA Vaccines & Therapeutics Market Size by Country
  6. 10.2.1 South America mRNA Vaccines & Therapeutics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America mRNA Vaccines & Therapeutics Market Size by Country (2021-2026)
  8. 10.2.3 South America mRNA Vaccines & Therapeutics Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa mRNA Vaccines & Therapeutics Sales by Country
  2. 11.1.1 Middle East and Africa mRNA Vaccines & Therapeutics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa mRNA Vaccines & Therapeutics Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa mRNA Vaccines & Therapeutics Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa mRNA Vaccines & Therapeutics Market Size by Country
  6. 11.2.1 Middle East and Africa mRNA Vaccines & Therapeutics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa mRNA Vaccines & Therapeutics Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa mRNA Vaccines & Therapeutics Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 mRNA Vaccines & Therapeutics Value Chain Analysis
  2. 12.1.1 mRNA Vaccines & Therapeutics Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 mRNA Vaccines & Therapeutics Production Mode & Process
  7. 12.2 mRNA Vaccines & Therapeutics Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 mRNA Vaccines & Therapeutics Distributors
  10. 12.2.3 mRNA Vaccines & Therapeutics Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst